 |
||||
|
||||
|
||||
|
||||
Previous Article | Next Article
The Journal of Neuroscience, July 1, 2000, 20(13):4922-4929
Selective Suppression of Inhibitory Synaptic Transmission by Nocistatin in the Rat Spinal Cord Dorsal Horn
Hanns Ulrich Zeilhofer, Uta Muth- Selbach, Hans Gühring, Katharina Erb, and Seifollah Ahmadi Department of Experimental and Clinical Pharmacology and Toxicology, University of Erlangen-Nürnberg, D-91054 Erlangen, Germany
Nociceptin/orphanin FQ (N/OFQ) and nocistatin (NST) are two recently identified neuropeptides with opposing effects on several CNS functions, including spinal nociception. The cellular mechanisms that underlie this antagonism are not known. Here, we have investigated the effects of both peptides on synaptic transmission mediated by the three fast neurotransmitters L-glutamate, glycine, and GABA in the superficial layers of the rat spinal cord horn, which constitute the first important site of integration of nociceptive information in the pain pathway. NST selectively reduced transmitter release from inhibitory interneurons via a presynaptic Bordetella pertussis toxin-sensitive mechanism but left excitatory glutamatergic transmission unaffected. In contrast, N/OFQ only inhibited excitatory transmission. In the rat formalin test, an animal model of tonic pain in which N/OFQ exerts antinociceptive activity, NST induced profound hyperalgesia after intrathecal application. Similar to glycine and GABAA receptor antagonists, NST had no significant effects in the rat tail-flick test, a model of acute thermal pain. Our results provide a cellular basis for the antagonism of N/OFQ and NST and suggest the existence of a so far unidentified membrane receptor for NST. In addition, they support a role of NST as an endogenous inhibitor of glycinergic and GABAergic neurotransmission in the sensory part of the spinal cord and as a mediator of spinal hyperalgesia.
Key words: nociceptin/orphanin FQ; nocistatin; nociception; pain; hyperalgesia; synaptic transmission; spinal cord slice
Copyright © 2000 Society for Neuroscience 0270-6474/00/20134922-08$05.00/0
This article has been cited by other articles:
H. U. Zeilhofer and G. Calo
Nociceptin/Orphanin FQ and Its Receptor--Potential Targets for Pain Therapy?
J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 423 - 429.
[Abstract] [Full Text] [PDF]
M. Inoue, T. Kawashima, R. G. Allen, and H. Ueda
Nocistatin and Prepro-Nociceptin/Orphanin FQ 160-187 Cause Nociception through Activation of Gi/o in Capsaicin-Sensitive and of Gs in Capsaicin-Insensitive Nociceptors, Respectively
J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 141 - 146.
[Abstract] [Full Text] [PDF]
S. Ahmadi, U. Muth-Selbach, A. Lauterbach, P. Lipfert, W. L. Neuhuber, and H. U. Zeilhofer
Facilitation of Spinal NMDA Receptor Currents by Spillover of Synaptically Released Glycine
Science, June 27, 2003; 300(5628): 2094 - 2097.
[Abstract] [Full Text] [PDF]
M. Inoue, T. Kawashima, H. Takeshima, G. Calo, A. Inoue, Y. Nakata, and H. Ueda
In Vivo Pain-Inhibitory Role of Nociceptin/Orphanin FQ in Spinal Cord
J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 495 - 501.
[Abstract] [Full Text] [PDF]
S. Meis
Nociceptin/Orphanin FQ: Actions within the Brain
Neuroscientist, April 1, 2003; 9(2): 158 - 168.
[Abstract] [PDF]
T. D. Moran and P. A. Smith
Morphine-3beta -D-glucuronide Suppresses Inhibitory Synaptic Transmission in Rat Substantia Gelatinosa
J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 568 - 576.
[Abstract] [Full Text] [PDF]
J. S. Mogil and G. W. Pasternak
The Molecular and Behavioral Pharmacology of the Orphanin FQ/Nociceptin Peptide and Receptor Family
Pharmacol. Rev., September 1, 2001; 53(3): 381 - 415.
[Abstract] [Full Text] [PDF]
S. Ahmadi, C. Kotalla, H. Gühring, H. Takeshima, A. Pahl, and H. U. Zeilhofer
Modulation of Synaptic Transmission by Nociceptin/Orphanin FQ and Nocistatin in the Spinal Cord Dorsal Horn of Mutant Mice Lacking the Nociceptin/Orphanin FQ Receptor
Mol. Pharmacol., March 1, 2001; 59(3): 612 - 618.
[Abstract] [Full Text]
|
|
|
|
 |
|